NORGINE B.V. ACQUIRES AZANTA A/S STRENGTHENING ITS POSITION AS A LEADING EUROPEAN SPECIALIST PHARMACEUTICAL COMPANY
Amsterdam, The Netherlands, 24 March 2020 Norgine B.V. (“Norgine”) announces the acquisition of Azanta A/S, a specialty biopharmaceutical company operating within women’s healthcare, addiction medicine and oncology. Azanta becomes a wholly-owned subsidiary of Norgine.
For the full press release click ‘Read more’ link below.